Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study

H. Pikhart, J. A. Hubáček, A. Peasey, R. Kubínová, M. Bobák

. 2015 ; 64 (Suppl 3) : S355-S361.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16031162

Dyslipidemia is the risk factor of cardiovascular disease, but the relationship between the plasma triglyceride (TG) levels and total/cardiovascular mortality has not yet been analyzed in Slavs. The aim of our study was to analyze the association between the fasting TG levels and all-cause/cardiovascular mortality. We have examined 3,143 males and 3,650 females, aged 58.3+/-7.1 years. 729 deaths (274 cardiovascular deaths) have been registered during up to 11.8 years of follow-up. Age-sex adjusted all-cause mortality was higher in individuals with TG values 3.01-4.00 mmol/l (HR 1.37, 95 % CI 1.02-1.83, P=0.035) and over 4.00 mmol/l (HR 1.66, 95 % CI 1.21-2.27, P=0.002) when compared with a reference group (TG 1.41-1.80 mmol/l). Elevated risk remains significant when adjusted for education, marital status and unemployment. When further adjusted for smoking, BMI and dyslipidemia interventions, HR for those in above 4.00 mmol/l group decreased (1.42, P=0.04). The results have been similar when cardiovascular mortality has been examined, however, results reached statistical significance only for the TG over 4.0 mmol/l (P=0.028). Our results confirmed that enhanced plasma levels of plasma triglycerides are dose dependently associated with increased risk of all-cause mortality, however, it seems that individuals with TG values 1.8-3.0 mmol/l are not in higher risk of death.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16031162
003      
CZ-PrNML
005      
20200630083238.0
007      
ta
008      
161101s2015 xr f 000 0|ENG||
009      
AR
024    7_
$a 10.33549/physiolres.933179 $2 doi
035    __
$a (PubMed)26680668
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a ENG
044    __
$a xr
100    1_
$a Pikhart, Hynek $u Department of Epidemiology and Public Health, University College London, London, United Kingdom $7 xx0107140
245    10
$a Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study / $c H. Pikhart, J. A. Hubáček, A. Peasey, R. Kubínová, M. Bobák
520    9_
$a Dyslipidemia is the risk factor of cardiovascular disease, but the relationship between the plasma triglyceride (TG) levels and total/cardiovascular mortality has not yet been analyzed in Slavs. The aim of our study was to analyze the association between the fasting TG levels and all-cause/cardiovascular mortality. We have examined 3,143 males and 3,650 females, aged 58.3+/-7.1 years. 729 deaths (274 cardiovascular deaths) have been registered during up to 11.8 years of follow-up. Age-sex adjusted all-cause mortality was higher in individuals with TG values 3.01-4.00 mmol/l (HR 1.37, 95 % CI 1.02-1.83, P=0.035) and over 4.00 mmol/l (HR 1.66, 95 % CI 1.21-2.27, P=0.002) when compared with a reference group (TG 1.41-1.80 mmol/l). Elevated risk remains significant when adjusted for education, marital status and unemployment. When further adjusted for smoking, BMI and dyslipidemia interventions, HR for those in above 4.00 mmol/l group decreased (1.42, P=0.04). The results have been similar when cardiovascular mortality has been examined, however, results reached statistical significance only for the TG over 4.0 mmol/l (P=0.028). Our results confirmed that enhanced plasma levels of plasma triglycerides are dose dependently associated with increased risk of all-cause mortality, however, it seems that individuals with TG values 1.8-3.0 mmol/l are not in higher risk of death.
650    _2
$a senioři $7 D000368
650    _2
$a kardiovaskulární nemoci $x krev $x mortalita $7 D002318
650    _2
$a omezení příjmu potravy $x krev $7 D005215
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mortalita $x trendy $7 D009026
650    12
$a surveillance populace $x metody $7 D011159
650    _2
$a rizikové faktory $7 D012307
650    _2
$a triglyceridy $x krev $7 D014280
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Laboratory for Atherosclerosis Research, Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Peasey, A. $u Department of Epidemiology and Public Health, University College London, London, United Kingdom
700    1_
$a Kubínová, Růžena, $d 1947- $7 xx0082854 $u National Institute of Public Health, Prague, Czech Republic
700    1_
$a Bobák, Martin, $d 1963- $7 xx0092245 $u Department of Epidemiology and Public Health, University College London, London, United Kingdom
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 64, Suppl 3 (2015), s. S355-S361
773    0_
$t Supplement on the occasion of the conference triglyceride and atherosclerosis $g (2015), s. S355-S361 $w MED00191410
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20161101 $b ABA008
991    __
$a 20200630083235 $b ABA008
999    __
$a ok $b bmc $g 1172736 $s 955820
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 64 $c Suppl 3 $d S355-S361 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    ##
$a 2015 $d S355-S361 $m Supplement on the occasion of the conference triglyceride and atherosclerosis $x MED00191410
LZP    __
$b NLK118 $a Pubmed-20161101

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...